Stock SUPN SUPERNUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Supernus Pharmaceuticals, Inc.

Equities

SUPN

US8684591089

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
27.87 USD -0.64% Intraday chart for Supernus Pharmaceuticals, Inc. -3.03% -3.70%
May. 08 Earnings Flash (SUPN) SUPERNUS PHARMACEUTICALS Reports Q1 Revenue $143.6M, vs. Street Est of $145.8M MT
May. 08 Transcript : Supernus Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Specialty & Advanced Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
 1.53B - - -
MERCK KGAA Stock Merck KGaA
 79.38B - -
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
 8.74B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
 4.94B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
 4.7B - -
YUHAN CORPORATION Stock Yuhan Corporation
 3.98B
  1. Stock Market
  2. Equities
  3. SUPN Stock
  4. Charts Supernus Pharmaceuticals, Inc.
  5. Sector Chart